# Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pembrolizumab-versus-placebo-as-post-nephrectomy-adjuvant-therapy-for-clear-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thomas Powles,Piotr Tomczak,Se Hoon Park,Balaji Venugopal,Thomas Ferguson,Stefan N. Symeonides,Jaroslav Hájek,Howard Gurney,Yen‐Hwa Chang,Jae‐Lyun Lee,Naveed Sarwar,Antoine Thiery-Vuillemin,Marine Gross‐Goupil,Mauricio Mahave,Naomi B. Haas,Piotr Sawrycki,Joseph E. Burgents,Lei Xu,Kentaro Imai,David I. Quinn,Toni K. Choueiri,Piotr Tomczak,Toni K. Choueiri,Se Hoon Park,Balaji Venugopal,Thomas Ferguson,Jaroslav Hájek,Tzu-Ping Lin,Stefan N. Symeonides,Jae‐Lyun Lee,Piotr Sawrycki,Naomi B. Haas,Howard Gurney,Mauricio Mahave,Naveed Sarwar,Antoine Thiery-Vuillemin,Marine Gross‐Goupil,Christine Chevreau,John M. Burke,Gurjyot K. Doshi,Bohuslav Melichar,Delphine Topart,Stéphane Oudard,Evgeniy Kopyltsov,H. Hammers,David I. Quinn,Ajjai Alva,Juliana de Menezes,Adriano Gonçalves e Silva,Eric Winquist,Alketa Hamzaj,Giuseppe Procopio,Boguslawa Karaszewska,Ewa M. Nowakowska-Zajdel,B. Yа. Alekseev,Rustem Gafanov,А. А. Измайлов,Andrey Semenov,S. G. Afanasyev,Oleg Lipatov,T.B. Powles,Sandy Srinivas,David F. McDermott,Samith T. Kochuparambil,Ian D. Davis,Katriina Peltola,Roberto Sabbatini,Jinsoo Chung,М. I. Shkolnik,В. Б. Матвеев,P. Gajate Borau,Steven McCune,Thomas E. Hutson,Alejandro Dri,Silvio Correia Sales,Carrie Yeung,Carmen Marcela Alcala Castro,Peter J. Boström,Brigitte Laguerre,Consuelo Buttigliero,Ugo De Giorgi,Eugeniy A. Fomin,Yousef Zakharia,Clara Hwang,Eric A. Singer,Jeffrey T. Yorio,David Waterhouse,Rubén Dario Kowalyszyn,Margarita Sonia Alfie,Eduardo Yañez Ruiz,Tomáš Büchler,Krista Kankaanranta,G. Ferretti,Go Kimura,Kazuo Nishimura,Naoya Masumori,Satoshi Tamada,Haruaki Kato,Hiroshi Kitamura,Iwona Danielewicz |
| Citations | 284 |
| DOI | 10.1016/s1470-2045(22)00487-9 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.thelancet.com/article/S1470204522004879/pdf |
| OpenAlex ID | https://openalex.org/W4293708418 |
| PMID | 36055304 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Toni K. Choueiri](https://scholariq.org/researchers/toni-k-choueiri/)
- [Masatoshi Eto](https://scholariq.org/researchers/masatoshi-eto/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.